The Roles of Graduate Students and Postdocs in the Emergence of Gene Editing: CRISPR Science and Technology
Curator: Aviva Lev-Ari, PhD, RN
2.1.5.13 The Roles of Graduate Students and Postdocs in the Emergence of Gene Editing: CRISPR Science and Technology, Volume 2 (Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS and BioInformatics, Simulations and the Genome Ontology), Part 2: CRISPR for Gene Editing and DNA Repair
PLAN TO ATTEND
Understanding CRISPR: Mechanisms and Applications: CHI, September 19-22, 2016, Westin Boston Waterfront, Boston
Announcement from LPBI Group: key code LPBI16 for Exclusive Discount to attend Boston’s Discovery on Target (September 19-22, 2016, CRISPR: Mechanisms to Applications on 9/19/2016)
The emergence of Gene Editing: CRISPR Science and Technology provide evidence that since the NIH effort to sequence the Genome, this endeavor is the second one to follow as an evolving scientific community ecosystem at their best in COMPETITION AND COLLABORATION, as well as in the survival of the fittest struggle that yielded a legal battle on appropriation of the discovery and the rights to its Intellectual Property (IP).
On our Journal we published
70 articles on Gene Editing: CRISPR Science and Technology
See references in
UPDATED – Status “Interference — Initial memorandum” – CRISPR/Cas9 – The Biotech Patent Fight of the Century: UC, Berkeley and Broad Institute @MIT
Reporter: Aviva Lev-Ari, PhD, RN
Background for Status “Interference – Initial memorandum”
From nature.com
From elsewhere
NATURE | NEWS FEATURE
The unsung heroes of CRISPR
The soaring popularity of gene editing has made celebrities of the principal investigators who pioneered the field — but their graduate students and postdocs are often overlooked.
Doudna and other principal investigators involved in the seminal work have become scientific celebrities: they are profiled in major newspapers, star in documentaries and are rumoured to be contenders for a Nobel prize. “When I came to the lab, I was the only person studying CRISPR,” Wiedenheft says. “When I left the lab, almost everyone was studying it.”
His work with Doudna yielded a First author place on their 2011 Nature article:
et al. Nature 477, 486–489 (2011).
In January 2016, Eric Lander, president of the Broad Institute of MIT and Harvard in Cambridge, Massachusetts, tossed into this minefield a historical portrait called ‘The Heroes of CRISPR
Cell 164, 18–28 (2016).
The Heroes of CRISPR
Editor of Cell received letters questioning the decision to publish Eric Lander’s article due to Broad Institute involvement in a legal dispute and presenting an incomplete picture of the evolution of the discovery and using a title that assigns the Heroism on a matter legally unsettled.
Does the Cell, 2016 article present all attributions due to:
1.The quiet revolutionary: How the co-discovery of CRISPR explosively changed Emmanuelle Charpentier’s life
The microbiologist spent years moving labs and relishing solitude. Then her work on gene-editing thrust her into the scientific spotlight.
27 April 2016
and
2. Bitter fight over CRISPR patent heats up
Unusual battle among academic institutions holds key to gene-editing tool’s future use.
credit in science goes to the Leader of the lab, as do any prizes that follow.
2012pharmaceutical
Amandeep Kaur
Aashir Awan, Phd
Abhisar Anand
Adina Hazan
Alan F. Kaul, PharmD., MS, MBA, FCCP
alexcrystal6
anamikasarkar
apreconasia
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Dror Nir
dsmolyar
Ethan Coomber
evelinacohn
Frason
Gail S Thornton
Irina Robu
jayzmit48
jdpmd
jshertok
kellyperlman
Ed Kislauskis
larryhbern
Madison Davis
marzankhan
megbaker58
ofermar2020
Dr. Pati
pkandala
ritusaxena
Rick Mandahl
sjwilliamspa
Srinivas Sriram
stuartlpbi
Dr. Sudipta Saha
tildabarliya
zraviv06
zs22
Leave a Reply